vs
Side-by-side financial comparison of Microchip Technology (MCHP) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.2B, roughly 1.3× Microchip Technology). Microchip Technology runs the higher net margin — 5.3% vs 4.4%, a 0.8% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 15.6%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $318.9M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -5.4%).
Microchip Technology Incorporated is an American publicly traded semiconductor corporation that manufactures microcontroller, mixed-signal, analog, and Flash-IP integrated circuits.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
MCHP vs ONC — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.5B |
| Net Profit | $62.7M | $66.5M |
| Gross Margin | 59.6% | 90.5% |
| Operating Margin | 12.8% | 12.4% |
| Net Margin | 5.3% | 4.4% |
| Revenue YoY | 15.6% | 32.8% |
| Net Profit YoY | 217.0% | 143.8% |
| EPS (diluted) | $0.06 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $970.5M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.2B | $1.0B | ||
| Q2 24 | $1.2B | $929.2M | ||
| Q1 24 | $1.3B | $751.7M |
| Q4 25 | $62.7M | $66.5M | ||
| Q3 25 | $41.7M | $124.8M | ||
| Q2 25 | $-18.6M | $94.3M | ||
| Q1 25 | $-154.6M | $1.3M | ||
| Q4 24 | $-53.6M | $-151.9M | ||
| Q3 24 | $78.4M | $-121.3M | ||
| Q2 24 | $129.3M | $-120.4M | ||
| Q1 24 | $154.7M | $-251.2M |
| Q4 25 | 59.6% | 90.5% | ||
| Q3 25 | 55.9% | 86.1% | ||
| Q2 25 | 53.6% | 87.5% | ||
| Q1 25 | 51.6% | 85.2% | ||
| Q4 24 | 54.7% | 85.8% | ||
| Q3 24 | 57.4% | 83.0% | ||
| Q2 24 | 59.4% | 85.1% | ||
| Q1 24 | 59.6% | 83.4% |
| Q4 25 | 12.8% | 12.4% | ||
| Q3 25 | 7.8% | 11.5% | ||
| Q2 25 | 3.0% | 6.7% | ||
| Q1 25 | -10.3% | 1.0% | ||
| Q4 24 | 3.0% | -7.0% | ||
| Q3 24 | 12.6% | -12.0% | ||
| Q2 24 | 17.7% | -11.5% | ||
| Q1 24 | 19.1% | -34.8% |
| Q4 25 | 5.3% | 4.4% | ||
| Q3 25 | 3.7% | 8.8% | ||
| Q2 25 | -1.7% | 7.2% | ||
| Q1 25 | -15.9% | 0.1% | ||
| Q4 24 | -5.2% | -13.5% | ||
| Q3 24 | 6.7% | -12.1% | ||
| Q2 24 | 10.4% | -13.0% | ||
| Q1 24 | 11.7% | -33.4% |
| Q4 25 | $0.06 | $0.05 | ||
| Q3 25 | $0.03 | $0.08 | ||
| Q2 25 | $-0.09 | $0.06 | ||
| Q1 25 | $-0.29 | $0.00 | ||
| Q4 24 | $-0.10 | $-0.10 | ||
| Q3 24 | $0.14 | $-0.09 | ||
| Q2 24 | $0.24 | $-0.09 | ||
| Q1 24 | $0.29 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $250.7M | $4.5B |
| Total DebtLower is stronger | $5.4B | $836.4M |
| Stockholders' EquityBook value | $6.6B | $4.4B |
| Total Assets | $14.3B | $8.2B |
| Debt / EquityLower = less leverage | 0.82× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $250.7M | $4.5B | ||
| Q3 25 | $236.8M | $4.0B | ||
| Q2 25 | $566.5M | $2.8B | ||
| Q1 25 | $771.7M | $2.5B | ||
| Q4 24 | $586.0M | $2.6B | ||
| Q3 24 | $286.1M | $2.7B | ||
| Q2 24 | $315.1M | $2.6B | ||
| Q1 24 | $319.7M | $2.8B |
| Q4 25 | $5.4B | $836.4M | ||
| Q3 25 | $5.4B | — | ||
| Q2 25 | $5.5B | — | ||
| Q1 25 | $5.6B | — | ||
| Q4 24 | $6.7B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | — | ||
| Q1 24 | $6.0B | — |
| Q4 25 | $6.6B | $4.4B | ||
| Q3 25 | $6.7B | $4.1B | ||
| Q2 25 | $6.9B | $3.8B | ||
| Q1 25 | $7.1B | $3.5B | ||
| Q4 24 | $6.0B | $3.3B | ||
| Q3 24 | $6.3B | $3.4B | ||
| Q2 24 | $6.4B | $3.4B | ||
| Q1 24 | $6.7B | $3.4B |
| Q4 25 | $14.3B | $8.2B | ||
| Q3 25 | $14.5B | $7.6B | ||
| Q2 25 | $15.0B | $6.3B | ||
| Q1 25 | $15.4B | $5.8B | ||
| Q4 24 | $15.6B | $5.9B | ||
| Q3 24 | $15.6B | $5.8B | ||
| Q2 24 | $15.8B | $5.7B | ||
| Q1 24 | $15.9B | $5.7B |
| Q4 25 | 0.82× | 0.19× | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 1.12× | — | ||
| Q3 24 | 1.02× | — | ||
| Q2 24 | 0.96× | — | ||
| Q1 24 | 0.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $341.4M | $417.3M |
| Free Cash FlowOCF − Capex | $318.9M | $379.8M |
| FCF MarginFCF / Revenue | 26.9% | 25.4% |
| Capex IntensityCapex / Revenue | 1.9% | 2.5% |
| Cash ConversionOCF / Net Profit | 5.44× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $819.9M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $341.4M | $417.3M | ||
| Q3 25 | $88.1M | $402.6M | ||
| Q2 25 | $275.6M | $263.6M | ||
| Q1 25 | $205.9M | $44.1M | ||
| Q4 24 | $271.5M | $75.2M | ||
| Q3 24 | $43.6M | $188.4M | ||
| Q2 24 | $377.1M | $-95.6M | ||
| Q1 24 | $430.0M | $-308.6M |
| Q4 25 | $318.9M | $379.8M | ||
| Q3 25 | $51.6M | $354.5M | ||
| Q2 25 | $257.7M | $219.8M | ||
| Q1 25 | $191.7M | $-12.3M | ||
| Q4 24 | $253.4M | $-17.3M | ||
| Q3 24 | $22.8M | $54.7M | ||
| Q2 24 | $304.2M | $-205.5M | ||
| Q1 24 | $389.9M | $-465.1M |
| Q4 25 | 26.9% | 25.4% | ||
| Q3 25 | 4.5% | 25.1% | ||
| Q2 25 | 24.0% | 16.7% | ||
| Q1 25 | 19.8% | -1.1% | ||
| Q4 24 | 24.7% | -1.5% | ||
| Q3 24 | 2.0% | 5.5% | ||
| Q2 24 | 24.5% | -22.1% | ||
| Q1 24 | 29.4% | -61.9% |
| Q4 25 | 1.9% | 2.5% | ||
| Q3 25 | 3.2% | 3.4% | ||
| Q2 25 | 1.7% | 3.3% | ||
| Q1 25 | 1.5% | 5.0% | ||
| Q4 24 | 1.8% | 8.2% | ||
| Q3 24 | 1.8% | 13.3% | ||
| Q2 24 | 5.9% | 11.8% | ||
| Q1 24 | 3.0% | 20.8% |
| Q4 25 | 5.44× | 6.28× | ||
| Q3 25 | 2.11× | 3.22× | ||
| Q2 25 | — | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.56× | — | ||
| Q2 24 | 2.92× | — | ||
| Q1 24 | 2.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MCHP
| Mixed Signal Microcontrollers | $586.5M | 49% |
| Analog | $322.9M | 27% |
| Other Product Line | $276.6M | 23% |
ONC
Segment breakdown not available.
